MCID: BDY001
MIFTS: 45

Body Dysmorphic Disorder

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Body Dysmorphic Disorder

MalaCards integrated aliases for Body Dysmorphic Disorder:

Name: Body Dysmorphic Disorder 12 77 38 15
Dysmorphophobia 12 77
Body Dysmorphic Disorders 74
Dysmorphic Syndrome 12
Body Dysmorphia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0060163
KEGG 38 H01447
UMLS 74 C0005887

Summaries for Body Dysmorphic Disorder

Disease Ontology : 12 A somatoform disorder that involves an excessive concern about and preoccupation with a perceived defect in his or her physical features (body image).

MalaCards based summary : Body Dysmorphic Disorder, also known as dysmorphophobia, is related to hypoparathyroidism-retardation-dysmorphism syndrome and aids dysmorphic syndrome. An important gene associated with Body Dysmorphic Disorder is TMEM94 (Transmembrane Protein 94), and among its related pathways/superpathways are Serotonergic synapse and Glycosaminoglycan metabolism. The drugs Levetiracetam and Norepinephrine have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and skin.

Wikipedia : 77 Body dysmorphic disorder (BDD), occasionally still called dysmorphophobia, is a mental disorder... more...

Related Diseases for Body Dysmorphic Disorder

Diseases related to Body Dysmorphic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 135)
# Related Disease Score Top Affiliating Genes
1 hypoparathyroidism-retardation-dysmorphism syndrome 12.4
2 aids dysmorphic syndrome 12.1
3 choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 12.1
4 intellectual disability-severe speech delay-mild dysmorphism syndrome 12.1
5 hypoparathyroidism-intellectual disability-dysmorphism syndrome 12.1
6 night blindness-skeletal anomalies-dysmorphism syndrome 11.9
7 hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome 11.9
8 intellectual disability-expressive aphasia-facial dysmorphism syndrome 11.9
9 congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome 11.9
10 birk-barel syndrome 11.9
11 overgrowth-macrocephaly-facial dysmorphism syndrome 11.9
12 thin ribs-tubular bones-dysmorphism syndrome 11.9
13 short stature-deafness-neutrophil dysfunction-dysmorphism syndrome 11.9
14 intellectual disability-obesity-brain malformations-facial dysmorphism syndrome 11.9
15 intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome 11.9
16 microcephaly-short stature-intellectual disability-facial dysmorphism syndrome 11.9
17 metopic ridging-ptosis-facial dysmorphism syndrome 11.9
18 intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome 11.9
19 osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome 11.9
20 x-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome 11.9
21 arachnodactyly - intellectual disability - dysmorphism 11.5
22 epiphyseal dysplasia hearing loss dysmorphism 11.4
23 kcnk9 imprinting syndrome 11.4
24 xia-gibbs syndrome 11.1
25 epileptic encephalopathy, early infantile, 23 11.1
26 culler-jones syndrome 11.0
27 short stature, hearing loss, retinitis pigmentosa, and distinctive facies 11.0
28 fibromatosis, gingival, with distinctive facies 10.8
29 hirschsprung disease with hypoplastic nails and dysmorphic facial features 10.8
30 spinocerebellar ataxia with dysmorphism 10.8
31 cubitus valgus with mental retardation and unusual facies 10.8
32 deafness, x-linked 7 10.8
33 fryns macrocephaly 10.8
34 dislocation of hip, congenital, with hyperextensibility of fingers and facial dysmorphism 10.8
35 spondylometaphyseal dysplasia with bowed forearms and facial dysmorphism 10.8
36 burn-mckeown syndrome 10.8
37 mental retardation with language impairment and with or without autistic features 10.8
38 beaulieu-boycott-innes syndrome 10.8
39 steel syndrome 10.8
40 mental retardation, autosomal recessive 39 10.8
41 mental retardation, autosomal dominant 23 10.8
42 tatton-brown-rahman syndrome 10.8
43 mental retardation, autosomal dominant 36 10.8
44 klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism 10.8
45 smith-kingsmore syndrome 10.8
46 mental retardation and distinctive facial features with or without cardiac defects 10.8
47 skraban-deardorff syndrome 10.8
48 med13l haploinsufficiency syndrome 10.8
49 reunion island larsen-like syndrome 10.8
50 cono-spondylar dysplasia 10.8

Graphical network of the top 20 diseases related to Body Dysmorphic Disorder:



Diseases related to Body Dysmorphic Disorder

Symptoms & Phenotypes for Body Dysmorphic Disorder

Drugs & Therapeutics for Body Dysmorphic Disorder

Drugs for Body Dysmorphic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 64)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Levetiracetam Approved, Investigational Phase 4 102767-28-2 441341
2
Norepinephrine Approved Phase 4 51-41-2 439260
3
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
4 Nootropic Agents Phase 4
5 Anticonvulsants Phase 4
6 Serotonin and Noradrenaline Reuptake Inhibitors Phase 4
7 Antidepressive Agents, Second-Generation Phase 4,Phase 3
8 Psychotropic Drugs Phase 4,Phase 3,Phase 2
9 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
10 Serotonin Agents Phase 4,Phase 3,Phase 2
11 Serotonin Uptake Inhibitors Phase 4,Phase 3,Phase 2
12 Antidepressive Agents Phase 4,Phase 3
13 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2
14 Venlafaxine Hydrochloride Phase 4
15 Cytochrome P-450 Enzyme Inhibitors Phase 4
16 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
17
Serotonin Investigational, Nutraceutical Phase 4,Phase 3,Phase 2 50-67-9 5202
18
Citalopram Approved Phase 3 59729-33-8 2771
19 Muscarinic Antagonists Phase 3
20 Autonomic Agents Phase 3,Phase 2
21 Antiparkinson Agents Phase 3,Not Applicable
22 Cholinergic Agents Phase 3
23 Cholinergic Antagonists Phase 3
24 Parasympatholytics Phase 3
25 Peripheral Nervous System Agents Phase 3,Phase 2,Not Applicable
26
Milk thistle Approved, Experimental, Investigational Phase 2 65666-07-1
27
Oxytocin Approved, Vet_approved Phase 2 50-56-6 439302 53477758
28
Ondansetron Approved Phase 2 99614-02-5 4595
29
Lactitol Investigational Phase 2 585-86-4, 585-88-6 493591
30 silymarin Phase 2
31 Antioxidants Phase 2
32 Protective Agents Phase 2
33 Oxytocics Phase 2
34 Hormones Phase 2
35 Serotonin Antagonists Phase 2
36 Central Nervous System Depressants Phase 2,Not Applicable
37 Serotonin Receptor Agonists Phase 2
38 Antipsychotic Agents Phase 2
39 Anti-Anxiety Agents Phase 2
40 Antiemetics Phase 2
41 Tranquilizing Agents Phase 2
42 Gastrointestinal Agents Phase 2
43 Antipruritics Phase 2
44 Dermatologic Agents Phase 2
45
Cycloserine Approved Early Phase 1 68-41-7 401 6234
46
Memantine Approved, Investigational Not Applicable 19982-08-2 4054
47
Dopamine Approved Not Applicable 62-31-7, 51-61-6 681
48
Cocaine Approved, Illicit Not Applicable 50-36-2 446220 5760
49
Diprenorphine Illicit, Vet_approved Not Applicable 14357-78-9
50 Renal Agents Early Phase 1

Interventional clinical trials:

(show all 39)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Completed NCT00265109 Phase 4 Levetiracetam
2 CBT as an Adjunct to SRIs in the Treatment of BDD Terminated NCT00211809 Phase 4 Venlafaxine
3 Fluoxetine in Pediatric Body Dysmorphic Disorder Completed NCT00245635 Phase 4 Fluoxetine;Placebo
4 Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder Completed NCT00149799 Phase 3 Escitalopram;Placebo
5 Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions Unknown status NCT01316627 Phase 2
6 Milk Thistle in Body Dysmorphic Disorder Recruiting NCT02843451 Phase 2 Milk Thistle;Placebo
7 Oxytocin Administration in BDD and OCD Completed NCT02671266 Phase 2 Oxytocin;Placebo
8 Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Terminated NCT01275248 Phase 2 Ondansetron;Placebo
9 Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder Unknown status NCT01453439 Not Applicable
10 Body Image and Self-Care in HIV-Infected MSM Unknown status NCT01817621 Not Applicable
11 Feasibility Pilot Study of Internet-based Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder With Global Recruitment Active, not recruiting NCT03517384 Not Applicable
12 Interpretation Bias Modification for Body Dysmorphic Disorder Completed NCT02635152 Not Applicable
13 A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder Recruiting NCT03773549
14 Attentional Bias in Body Dysmorphic Disorder Completed NCT01398904
15 Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD) Completed NCT01850433 Not Applicable
16 D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder Completed NCT00842309 Early Phase 1 d-cycloserine;Placebo
17 Smartphone-based Cognitive-Behavioral Therapy and Smartphone-based Supportive Psychotherapy for Body Dysmorphic Disorder Not yet recruiting NCT03673046 Not Applicable
18 Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder Active, not recruiting NCT03221738 Not Applicable
19 Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder Completed NCT00106223 Not Applicable
20 Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder Completed NCT01002326 Not Applicable
21 Internet Delivered CBT for Body Dysmorphic Disorder Completed NCT02010619 Not Applicable
22 An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder Completed NCT01038128 Not Applicable Memantine
23 Prevention of Body Image Disorder by Nurse Intervention on the Patient and Family Prior to Breast and Colon Surgery Completed NCT03726801 Not Applicable
24 Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD) Completed NCT00871143 Not Applicable
25 Escitalopram Neuroimaging Supplement Completed NCT01398865
26 Contribution of a Virtual Reality Program in the Treatment of Dysmorphophobia for Adolescent Female With Anorexia Nervosa Recruiting NCT03426930 Not Applicable
27 Body Image Disorder in Anorexia Nervosa and Virtual Reality Recruiting NCT03118921 Not Applicable
28 Brain Correlates of Self-Focused Processing Recruiting NCT02808702 Not Applicable
29 White Light Scanning to Aid Body Contouring: A Pilot Project Recruiting NCT01093950
30 Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study Completed NCT02524301 Not Applicable Positron Emission Tomography using [11C]diprenorphine
31 Assessment of Body Image in Patients With Rheumatoid Arthritis Completed NCT00832910
32 Effectiveness of Dance on Patients With Fibromyalgia Completed NCT00961805 Not Applicable
33 Impairment of Central Coherence in Restrictive Anorexia Nervosa (CoCA) Completed NCT02381639 Not Applicable
34 Cortical Excitability in Obsessive-Compulsive and Related Disorders Completed NCT00029068
35 Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders Withdrawn NCT01953042 Not Applicable
36 Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals Active, not recruiting NCT01075672 Not Applicable
37 Effects of Mindfulness Meditation on Rhinoplasty Outcomes Not yet recruiting NCT03727815 Not Applicable
38 The Pride Body Project Recruiting NCT03451513 Not Applicable
39 Investigation of Physical Activity and Associated Factors in Lower Extremity Amputees Recruiting NCT03825432

Search NIH Clinical Center for Body Dysmorphic Disorder

Genetic Tests for Body Dysmorphic Disorder

Anatomical Context for Body Dysmorphic Disorder

MalaCards organs/tissues related to Body Dysmorphic Disorder:

42
Brain, Eye, Skin, Breast, Colon, Testes, Bone

Publications for Body Dysmorphic Disorder

Articles related to Body Dysmorphic Disorder:

(show top 50) (show all 642)
# Title Authors Year
1
Direct comparisons of anorexia nervosa and body dysmorphic disorder: A systematic review. ( 30784781 )
2019
2
Application of a transdiagnostic treatment for emotional disorders to body dysmorphic disorder: A randomized controlled trial. ( 30445389 )
2019
3
High Prevalence of Body Dysmorphic Disorder and Moderate to Severe Appearance-Related Obsessive-Compulsive Symptoms Among Rhinoplasty Candidates. ( 30607575 )
2019
4
Intranasal oxytocin modulates higher order social cognition in body dysmorphic disorder. ( 30614171 )
2019
5
Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial. ( 30647044 )
2019
6
Body dysmorphic disorder and its relationship to sexuality, impulsivity, and addiction. ( 30658211 )
2019
7
A Practical Guide to Managing Body Dysmorphic Disorder in the Cosmetic Surgery Setting. ( 30676626 )
2019
8
Body dysmorphic disorder The drive for perfection. ( 30720669 )
2019
9
Understanding and treating body dysmorphic disorder. ( 30745686 )
2019
10
Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder: A Randomized Clinical Trial. ( 30785624 )
2019
11
Identifying Efficacious Treatment Elements for Refractory Conditions, Such as Body Dysmorphic Disorder. ( 30785632 )
2019
12
Body dysmorphic disorder: The drive for perfection. ( 30801405 )
2019
13
Internet-based, therapist-guided, cognitive-behavioural therapy for body dysmorphic disorder with global eligibility for inclusion: an uncontrolled pilot study. ( 30904854 )
2019
14
Shame and Defectiveness Beliefs in Treatment Seeking Patients With Body Dysmorphic Disorder. ( 29557815 )
2018
15
Escalation from normal appearance related intrusive cognitions to clinical preoccupations in Body Dysmorphic Disorder: A cross-sectional study. ( 29704773 )
2018
16
New perspectives in the treatment of body dysmorphic disorder. ( 29636904 )
2018
17
A systematic review and meta-analysis of cognitive processing deficits associated with body dysmorphic disorder. ( 29935380 )
2018
18
Patients Screening Positive for Body Dysmorphic Disorder Show No Significant Health-Related Quality of Life Gain after Functional Septorhinoplasty at a Tertiary Referral Center. ( 29702720 )
2018
19
Body dysmorphic disorder: a guide to identification and management for the orthodontic team. ( 29952250 )
2018
20
The classification of body dysmorphic disorder symptoms in male and female adolescents. ( 28858657 )
2018
21
Non-weight-related body image concerns and Body Dysmorphic Disorder prevalence in patients with Anorexia Nervosa. ( 29886274 )
2018
22
Pharmacological Treatment Of Body Dysmorphic Disorder. ( 29701157 )
2018
23
Body dysmorphic disorder in the cosmetic practice. ( 29667794 )
2018
24
Cosmetic Surgery and Body Dysmorphic Disorder - An Update. ( 29872676 )
2018
25
Affect and worry during a checking episode: A comparison of individuals with symptoms of obsessive-compulsive disorder, anorexia nervosa, bulimia nervosa, body dysmorphic disorder, illness anxiety disorder, and panic disorder. ( 30599438 )
2018
26
Aberrant Dynamic Connectivity for Fear Processing in Anorexia Nervosa and Body Dysmorphic Disorder. ( 29997532 )
2018
27
Influencing Factors of Social Anxiety Disorder and Body Dysmorphic Disorder in a Nonclinical Brazilian Population. ( 30388392 )
2018
28
An experimental test of the role of appearance-related safety behaviors in body dysmorphic disorder, social anxiety, and body dissatisfaction. ( 30307259 )
2018
29
Prevalence of bullying in a pediatric sample of body dysmorphic disorder. ( 30193152 )
2018
30
Conscious Perception of Facial Asymmetry in a Unilateral Cleft Lip Model: Body Dysmorphic Disorder Is an Exclusion Criterion. ( 30223679 )
2018
31
The relationship between body dysmorphic disorder and obsessive-compulsive disorder: A systematic review of direct comparative studies. ( 30238784 )
2018
32
Body dysmorphic disorder: A diagnostic challenge in adolescence. ( 30263210 )
2018
33
Plastic surgery in gynaecology: Factors affecting women's decision to undergo labiaplasty. Mind the risk of body dysmorphic disorder: A review. ( 30351259 )
2018
34
A psychiatric condition ...: Body dysmorphic disorder: a guide to identification and management for the orthodontic team. ( 30412528 )
2018
35
Skin, Body Dysmorphic Disorder, and Other Syndromes. ( 30482571 )
2018
36
An Internet-based controlled trial of interpretation bias modification versus progressive muscle relaxation for body dysmorphic disorder. ( 30589349 )
2018
37
Visual training program for body dysmorphic disorder: protocol for a novel intervention pilot and feasibility trial. ( 30598835 )
2018
38
Body dysmorphic disorder in pediatric dermatology. ( 29984846 )
2018
39
Effects of induced appearance-related interpretation bias: A test of the cognitive-behavioral model of body dysmorphic disorder. ( 30118967 )
2018
40
An initial investigation of the unique relationship between disgust propensity and body dysmorphic disorder. ( 30153602 )
2018
41
Validation of Spanish Language Evaluation Instruments for Body Dysmorphic Disorder and the Dysmorphic Concern Construct. ( 28713311 )
2017
42
The neurobiology of body dysmorphic disorder: A systematic review and theoretical model. ( 29017915 )
2017
43
Prevalence of body dysmorphic disorder and associated features in German adolescents: A self-report survey. ( 28482195 )
2017
44
Evaluation of the Body Parts That Preoccupy Adolescents With Body Dysmorphic Disorder. ( 29099545 )
2017
45
Neurocognitive Functioning in Young Adults with Subclinical Body Dysmorphic Disorder. ( 28367586 )
2017
46
Long-Term Outcomes of Cognitive-Behavioral Therapy for Adolescent Body Dysmorphic Disorder. ( 28577583 )
2017
47
Body dysmorphic disorder: A serious concern for our young generation. ( 28784390 )
2017
48
Insight in body dysmorphic disorder (BDD) relative to obsessive-compulsive disorder (OCD) and psychotic disorders: Revisiting this issue in light of DSM-5. ( 28651226 )
2017
49
Face and Object Perception in Body Dysmorphic Disorder versus Obsessive-Compulsive Disorder: The Mooney Faces Task. ( 28528596 )
2017
50
[Body dysmorphic disorder : Diagnostics and treatment in cosmetic dermatology]. ( 29075869 )
2017

Variations for Body Dysmorphic Disorder

Copy number variations for Body Dysmorphic Disorder from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 63474 12 119100000 132349534 Deletion FBXW8 dysmorphic
2 63477 12 119100000 132349534 Deletion FZD10 dysmorphic
3 63480 12 119100000 132349534 Deletion NCOR2 dysmorphic
4 63483 12 119100000 132349534 Deletion P2RX2 dysmorphic
5 63486 12 119100000 132349534 Deletion RAN dysmorphic
6 63489 12 119100000 132349534 Deletion STX2 dysmorphic
7 63492 12 119100000 132349534 Deletion TBX3 dysmorphic
8 63495 12 119100000 132349534 Deletion TESC dysmorphic
9 63498 12 119100000 132349534 Deletion ULK1 dysmorphic

Expression for Body Dysmorphic Disorder

Search GEO for disease gene expression data for Body Dysmorphic Disorder.

Pathways for Body Dysmorphic Disorder

Pathways related to Body Dysmorphic Disorder according to KEGG:

38
# Name Kegg Source Accession
1 Serotonergic synapse hsa04726

Pathways related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.46 GPC1 GPC3 GPC4 GPC6
2
Show member pathways
12.17 GPC1 GPC3 GPC4 GPC6
3
Show member pathways
12.1 GPC1 GPC3 GPC6
4
Show member pathways
12.03 GPC1 GPC3 GPC6
5
Show member pathways
12 GPC1 GPC3 GPC6
6
Show member pathways
11.97 GPC1 GPC3 GPC4 GPC6
7
Show member pathways
11.6 GPC1 GPC3 GPC6
8
Show member pathways
11.59 GPC1 GPC3 GPC4 GPC6
9
Show member pathways
11.09 GPC1 GPC3 GPC4 GPC6

GO Terms for Body Dysmorphic Disorder

Cellular components related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 GPC1 GPC4 GPC6 SLITRK1
2 collagen-containing extracellular matrix GO:0062023 9.62 GPC1 GPC3 GPC4 GPC6
3 glutamatergic synapse GO:0098978 9.58 GPC4 GPC6 SLITRK1
4 anchored component of membrane GO:0031225 9.56 GPC1 GPC3 GPC4 GPC6
5 Golgi lumen GO:0005796 9.46 GPC1 GPC3 GPC4 GPC6
6 intrinsic component of plasma membrane GO:0031226 9.37 GPC1 GPC3
7 lysosomal lumen GO:0043202 9.26 GPC1 GPC3 GPC4 GPC6
8 anchored component of plasma membrane GO:0046658 8.92 GPC1 GPC3 GPC4 GPC6

Biological processes related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 retinoid metabolic process GO:0001523 9.56 GPC1 GPC3 GPC4 GPC6
2 regulation of signal transduction GO:0009966 9.46 GPC1 GPC3 GPC4 GPC6
3 Wnt signaling pathway, planar cell polarity pathway GO:0060071 9.43 GPC4 GPC6
4 regulation of presynapse assembly GO:1905606 9.4 GPC4 SLITRK1
5 synaptic membrane adhesion GO:0099560 9.37 GPC4 SLITRK1
6 regulation of neurotransmitter receptor localization to postsynaptic specialization membrane GO:0098696 9.32 GPC4 GPC6
7 glycosaminoglycan biosynthetic process GO:0006024 9.26 GPC1 GPC3 GPC4 GPC6
8 glycosaminoglycan catabolic process GO:0006027 8.92 GPC1 GPC3 GPC4 GPC6

Molecular functions related to Body Dysmorphic Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway GO:1904929 8.62 GPC4 GPC6

Sources for Body Dysmorphic Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....